Michael Schwartz, MD
Urology · New Hyde Park, NYNPI 1669639738
Payments from drug & device makers
Across 32 payments — averaging $149.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$3K
- BD$488
- Procept Biorobotics Corporation$448
- Stryker$208
- Intuitive Surgical$200
- EDAP Technomed Inc$198
- plus $231 from 2 others
What the payments were for
- Consulting fees$3,48873%
- Speaking & faculty fees$2004%
- Food & beverage$1,08523%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 19 | $3,000 |
| BD | 1 | $488 |
| Procept Biorobotics Corporation | 4 | $448 |
| Stryker | 2 | $208 |
| Intuitive Surgical | 1 | $200 |
| EDAP Technomed Inc | 1 | $198 |
| Angiodynamics, Inc. | 1 | $174 |
| Boehringer Ingelheim | 3 | $57 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AquaBeam Robotic System$336
- DA VINCI SP$200
- FOCAL ONE$198
- Nanoknife$174
- VSP SYSTEM, VSP CRANIAL$125
How this compares
$4,773 in reported general payments places this provider in the 60th percentile of 952 urology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 13 | $11,317 |
| Tamsulosin Hcl | 295 | $6,201 |
| Finasteride | 202 | $3,202 |
| Trospium Chloride | 56 | $2,716 |
| Potassium Citrate ErPotassium Citrate | 11 | $1,737 |
| Silodosin | 11 | $1,629 |
| Tadalafil | 13 | $1,456 |
| Estradiol | 12 | $1,109 |
| Bicalutamide | 32 | $1,006 |
| Oxybutynin Chloride ErOxybutynin Chloride | 34 | $726 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 31 | $518 |
| Cefpodoxime Proxetil | 11 | $329 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 18 | $143 |
| Ciprofloxacin Hcl | 23 | $102 |
| Oxycodone Hcl | 17 | $35 |
Paid to pharmacies, not to this prescriber.
Other urology in New Hyde Park
- Manish ViraNew Hyde Park$2.1M
- Carl OlssonNew Hyde Park$366K
- Ardeshir RastinehadNew Hyde Park$304K
- Christopher PieczonkaSyracuse$31.2M
- Guarionex DecastroNew York$5.7M
- Mitchell EfrosGarden City$4.2M
- James McKiernanNew York$4.1M
- William HuangNew York$3.9M
- Jed KaminetskyMiddle Village$3.5M
- Evan GoldfischerPoughkeepsie$3.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.